Thomas Meier, Dr. serves as the Chairman of the Board at MUVON Therapeutics AG and Novaremed AG, with additional roles including Board Member at Onconetix Inc. and Visgenx, Inc., and Managing Partner at Viopas Venture Consulting GmbH. As Co-Founder and Chairman of the Board of SEAL Therapeutics AG, Thomas also holds a position as Partner at Board Advisors Deutschland AG. Previously, Thomas was the Chairman of the Board at PharmaBiome AG and has been involved with Santhera Pharmaceuticals since its founding, serving as Chairman of the Board, Chief Executive Officer, Chief Scientific Officer, and a member of the Board. Thomas's educational background includes postdoctoral fellowships and earning a PhD in Zoology/Animal Biology from the University of Basel and University of Geneva, alongside a High Performance Leadership Program certificate from IMD.
This person is not in the org chart
This person is not in any teams
This person is not in any offices